NEW YORK, Oct. 26 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced that the Company will attend several investor conferences in November.
The Company will present at the CIBC World Markets 18th Annual Healthcare Conference on Tuesday, November 6, 2007 at the Waldorf-Astoria Hotel in New York City. Management is currently scheduled to present at 1:55 p.m. ET. On November 15th & 16th, & 19th, management will be meeting with institutional investors at the Credit Suisse China Healthcare Sector Tour in New York City, Boston and London.
The Company will also attend the Lazard Capital Markets Healthcare Conference on November 27-28th and the Piper Jaffray Healthcare Conference on November 27-29th. Both events will take place in New York City.
Institutional investors who are interested in attending these events should contact their institutional sales representatives.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering is a leading, fully integrated, plant based pharmaceutical and plant based nutraceutical company dedicated to improving health through the development, manufacture and commercialization of modernized plant based products in China.
Safe Harbor Statement
This news release contains forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements include statements concerning plans, objectives, goals,
strategies, future events or performance, and underlying assumptions and
other statements that are other than statements of historical facts. Thes
|SOURCE American Oriental Bioengineering, Inc.|
Copyright©2007 PR Newswire.
All rights reserved